Atlas Trials

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Clinical trial NCT07332221 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07332221
Sponsor
Henan Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2026-01-20
Primary completion
2029-10-01
Enrollment
435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.